Western Pacific Wealth Management’s Live Nation Entertainment LYV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-715
Closed -$117K – 191
2025
Q3
$117K Sell
715
-92
-11% -$14.5K 0.11% 90
2025
Q2
$122K Sell
807
-60
-7% -$8.26K 0.12% 92
2025
Q1
$113K Hold
867
– – 0.1% 93
2024
Q4
$112K Buy
867
+82
+10% +$10.3K 0.09% 100
2024
Q3
$86K Sell
785
-81
-9% -$7.83K 0.06% 136
2024
Q2
$81.2K Sell
866
-259
-23% -$24.5K 0.06% 115
2024
Q1
$119K Buy
1,125
+144
+15% +$13.6K 0.09% 87
2023
Q4
$91.8K Buy
981
+134
+16% +$11.5K 0.07% 99
2023
Q3
$70.3K Hold
847
– – 0.06% 109
2023
Q2
$77.2K Hold
847
– – 0.06% 107
2023
Q1
$59.3K Hold
847
– – 0.05% 126
2022
Q4
$59.1K Buy
847
+272
+47% +$20.2K 0.05% 119
2022
Q3
$43K Buy
575
+554
+2,638% +$49.6K 0.04% 110
2022
Q2
$1K Buy
21
+1
+5% +$96 ﹤0.01% 187
2022
Q1
$2K Sell
20
-1
-5% -$114 ﹤0.01% 197
2021
Q4
$2K Buy
+21
New +$2.26K ﹤0.01% 207

Other funds holding LYV

Western Pacific Wealth Management's LYV Position: Q4 2025 in Review

Western Pacific Wealth Management sold out of Live Nation Entertainment (LYV) in Q4 2025, closing a stake of 715 shares — an estimated $117K sold.

Western Pacific Wealth Management first reported a position in LYV in Q4 2021 and held it in 16 quarters. The position peaked at $122K in Q2 2025. 775 funds tracked by Wall St. Rank hold LYV as of Q4 2025.

  • Western Pacific Wealth Management reported no remaining Live Nation Entertainment position as of Q4 2025 after selling out during the quarter.
  • Western Pacific Wealth Management sold 715 Live Nation Entertainment shares in Q4 2025, an estimated $117K.
  • Western Pacific Wealth Management first reported a position in Live Nation Entertainment in Q4 2021 and held it in 16 quarters.
  • Western Pacific Wealth Management's Live Nation Entertainment position peaked at $122K in Q2 2025.
  • 775 funds tracked by Wall St. Rank held Live Nation Entertainment as of Q4 2025.

Based on Western Pacific Wealth Management's 13F filing for Q4 2025, filed 4 Feb 2026.